A245620 Stock Overview
Provides genetic information analysis services in South Korea. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Eone Diagnomics Genome Center Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩415.00 |
| 52 Week High | ₩2,075.00 |
| 52 Week Low | ₩349.00 |
| Beta | -2.54 |
| 11 Month Change | 0% |
| 3 Month Change | -5.25% |
| 1 Year Change | -76.14% |
| 33 Year Change | -92.30% |
| 5 Year Change | -84.60% |
| Change since IPO | -92.52% |
Recent News & Updates
Recent updates
There's No Escaping Eone Diagnomics Genome Center Co., Ltd.'s (KOSDAQ:245620) Muted Revenues Despite A 43% Share Price Rise
Feb 29
Is Eone Diagnomics Genome Center (KOSDAQ:245620) Weighed On By Its Debt Load?
Apr 06If You Had Bought Eone Diagnomics Genome Center (KOSDAQ:245620) Shares A Year Ago You'd Have Earned 54% Returns
Feb 24Do Insiders Own Lots Of Shares In Eone Diagnomics Genome Center Co., Ltd. (KOSDAQ:245620)?
Jan 20Eone Diagnomics Genome Center (KOSDAQ:245620) Is Carrying A Fair Bit Of Debt
Dec 16Shareholder Returns
| A245620 | KR Life Sciences | KR Market | |
|---|---|---|---|
| 7D | 0% | -3.6% | 2.4% |
| 1Y | -76.1% | 32.4% | -4.0% |
Return vs Industry: A245620 underperformed the KR Life Sciences industry which returned 5.3% over the past year.
Return vs Market: A245620 underperformed the KR Market which returned 5.8% over the past year.
Price Volatility
| A245620 volatility | |
|---|---|
| A245620 Average Weekly Movement | n/a |
| Life Sciences Industry Average Movement | 9.1% |
| Market Average Movement | 5.6% |
| 10% most volatile stocks in KR Market | 11.5% |
| 10% least volatile stocks in KR Market | 2.7% |
Stable Share Price: A245620's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine A245620's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2013 | 103 | Min Seob Lee | www.edgc.com |
Eone Diagnomics Genome Center Co., Ltd. provides genetic information analysis services in South Korea. It engages in the genome research and development, genomic testing/screening, IT, and software activities.
Eone Diagnomics Genome Center Co., Ltd. Fundamentals Summary
| A245620 fundamental statistics | |
|---|---|
| Market cap | ₩57.44b |
| Earnings (TTM) | -₩39.88b |
| Revenue (TTM) | ₩73.97b |
0.8x
P/S Ratio-1.4x
P/E RatioIs A245620 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A245620 income statement (TTM) | |
|---|---|
| Revenue | ₩73.97b |
| Cost of Revenue | ₩65.86b |
| Gross Profit | ₩8.11b |
| Other Expenses | ₩47.99b |
| Earnings | -₩39.88b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -288.15 |
| Gross Margin | 10.96% |
| Net Profit Margin | -53.92% |
| Debt/Equity Ratio | 76.8% |
How did A245620 perform over the long term?
See historical performance and comparison